Cite
Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer
MLA
Harvey Kreisman, et al. “Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer.” Journal of Clinical Oncology, vol. 23, Sept. 2005, pp. 5918–28. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....658cd57d761b5eea8344e4fcc6f15fd3&authtype=sso&custid=ns315887.
APA
Harvey Kreisman, Larry Kleinberg, Abdenour Nabid, Solomon Hamburg, Walter J. Curran, William Spanos, Luis Souhami, Wilson Roa, Hak Choy, Baldassarre Stea, Joseph Ayoub, Pablo J. Cagnoni, Charles E. Scott, Colum Smith, & Adam P. Boyd. (2005). Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology, 23, 5918–5928.
Chicago
Harvey Kreisman, Larry Kleinberg, Abdenour Nabid, Solomon Hamburg, Walter J. Curran, William Spanos, Luis Souhami, et al. 2005. “Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer.” Journal of Clinical Oncology 23 (September): 5918–28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....658cd57d761b5eea8344e4fcc6f15fd3&authtype=sso&custid=ns315887.